Abstract
No public abstract is available from the verified source records.
Haley D. Watson, Kirstin J. Kooda
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
ror
Confidence 99%
pubmed
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Unresolved referenced work
Kept as external metadata until matched
Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America
10.1164/rccm.201908-1581st · 2019
Active bacterial core surveillance for legionellosis - United States, 2011-2013
10.15585/mmwr.mm6442a2 · 2015
Mycoplasma pneumoniae infections in hospitalized children — United States, 2018–2024
10.15585/mmwr.mm7423a1 · 2025
Comparative effectiveness of azithromycin versus doxycycline in hospitalized patients with community acquired pneumonia treated with beta-lactams: a multicenter matched cohort study
10.1093/cid/ciaf252 · 2026
Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions
10.1093/jac/dkh519 · 2005
Efficacy of azithromycin in the treatment of community-acquired pneumonia, including patients with macrolide-resistant Streptococcus pneumoniae infection
10.2169/internalmedicine.48.1482 · 2009
The cardiotoxicity of macrolides: a systematic review
10.31083/ph.2010.0644 · 2010
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
datacite
Confidence 0%
Azithromycin and the risk of cardiovascular death
10.1056/nejmoa1003833 · 2012
Association of azithromycin with mortality and cardiovascular events among older patients hospitalized with pneumonia
10.1001/jama.2014.4304 · 2014
Association of azithromycin with mortality and cardiovascular events among older patients hospitalized with pneumonia
10.1001/jama.2014.4304 · doi-reference
Azithromycin and the risk of cardiovascular death
10.1056/nejmoa1003833 · doi-reference
The cardiotoxicity of macrolides: a systematic review
10.31083/ph.2010.0644 · doi-reference
Efficacy of azithromycin in the treatment of community-acquired pneumonia, including patients with macrolide-resistant Streptococcus pneumoniae infection
10.2169/internalmedicine.48.1482 · doi-reference
Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions
10.1093/jac/dkh519 · doi-reference
Comparative effectiveness of azithromycin versus doxycycline in hospitalized patients with community acquired pneumonia treated with beta-lactams: a multicenter matched cohort study
10.1093/cid/ciaf252 · doi-reference
Mycoplasma pneumoniae infections in hospitalized children — United States, 2018–2024
10.15585/mmwr.mm7423a1 · doi-reference
Active bacterial core surveillance for legionellosis - United States, 2011-2013
10.15585/mmwr.mm6442a2 · doi-reference
Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America
10.1164/rccm.201908-1581st · doi-reference